ko ko ko en ko en en en en en en en en en en en ko en ceb en ko ko ko en ko ko ko ko ko ko en en en hu hu hu ko ko en ko en en en hu hu hu ko ko en ko en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko en ko en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko ko en en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko ko ko en en en hu hu hu ko ko en en ko ko ko en en th en en en en en en en en en en ko ko ko ko en ko ko en en en en en ko en ko ko en en en es en en en en en es es en pl es
향후 AI 성능은 임상 판단을 앞지르게 될까요?
A thought-provoking final debate closed MDS Virtual Congress 2020. The motion—Will artificial...
The Alzheimer’s disease patient journey starts with detection and progresses through to...
뇌 건강을 손상시키고 알츠하이머병의 위험을 증가시키는 요인
Knowing the factors that increase the risk of Alzheimer’s disease can help healthcare...
알츠하이머병의 위험이 있는 사람들을 식별하기 위한, 보다 접근 가능하고 가격이 적당한 새로운 기술
In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or...
아밀로이드 PET 이미징 기술이 진단 및 치료에 가져오는 변화
Access to amyloid PET changes the diagnosis and care of many patients in whom the diagnosis of...
읽기 시간: 2 분
운동이 파킨슨병에 미치는 질병 조절 효과
Aerobic exercise and resistance training slow the progression of the motor manifestations of...
읽기 시간: 2 분
2020 Update on strategies to improve motor symptoms
In 2020, when should a person diagnosed with Parkinson’s disease start treatment? Which...
읽기 시간: 3 분
어떤 타우 바이오마커가 알츠하이머병 관련 정보를 가장 많이 담고 있는가?
Aggregates of hyperphosphorylated and C-terminally truncated microtubule-associated tau protein are...
읽기 시간: 2 분
DSM-5 혼재성 양상 특정형을 어떻게 맞춤 치료를 할 수 있을까요?
The mixed features specifier for manic and depressive episodes introduced in DSM-5 reflects the...
읽기 시간: 5 분
미가공 데이터를 실질적 지식으로 전환하는 머신러닝
We are in the age of big data. The number of biomedical variables that can be measured has exploded...
읽기 시간: 3 분
전임상 알츠하이머병을 발견할 수 있는 빠르고 간편한 두 가지 기술
Alzheimer’s disease (AD) is preceded by an asymptomatic (preclinical) phase that may last...
읽기 시간: 3 분
혼재성 양상을 동반하는 주요우울장애의 진단 및 관리
One in five people with major depressive disorder (MDD) have at least three hypomanic symptoms, and...
본 웹사이트의 정보는 룬드벡이 제공합니다
© 2021 Copyright by Lundbeck Korea. All rights reserved.
Progress in Mind Korea
한국룬드벡 개인정보 처리방침 및 홈페이지 개인정보 처리방침
Progress in Mind 서비스 이용약관
Lundbeck Korea Co., Ltd. 19F, Korea AD Culture Center | 137, Olympic-ro 35-gil | Songpa-gu | 05510 | Seoul | Korea
Phone +82 2 431 6600 | Fax +82 2 431 6886
The products discussed herein may have different labeling in different countries
This information - including product information - is intended only for residents of the Republic of Korea.
Otsuka Australia Pharmaceutical Pty. Ltd
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
Not located in Brazil?
Go to a different regional HUB
Continue to Progress in MindContinue to Progress in Mind BrazilContinue to Progress in Mind MENAContinue to Progress in Mind SpainContinue to Progress in Mind ItalyContinue to Progress in Mind GreeceContinue to Progress in Mind South East AsiaContinue to Progress in Mind Middle East & AfricaContinue to Progress in Mind United KingdomContinue to Progress in Mind SwedenContinue to Progress in Mind NorgeContinue to Progress in Mind DenmarkContinue to Progress in Mind FinlandContinue to Progress in Mind Japan RCContinue to Progress in Mind БълrapияContinue to Progress in Mind IsraelContinue to Progress in Mind SwedenContinue to Progress in Mind FinlandContinue to Progress in Mind UkraineContinue to Progress in Mind Belgium & LuxembourgContinue to Progress in Mind SwitzerlandContinue to Progress in Mind GermanyContinue to Progress in Mind Austria
Progress in Mind Korea
HCP 접근 확인이 요구됨
이메일로 로그인 신규 가입하기
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country
Seleccione el país desde el cual nos visita